BIS监测下瑞马唑仑复合丙泊酚在老年髋关节脱位手法复位中的应用效果

doi:10.3760/cma.j.issn.1007-1245.2024.20.019

摘要/Abstract

摘要：

目的　探究脑电双频指数（BIS）监测下瑞马唑仑复合丙泊酚在老年髋关节脱位手法复位中的应用效果。方法　前瞻性选取2021年1月至2022年12月商洛市中医医院收治的75例需行手法复位的老年髋关节脱位患者作为研究对象。男44例，女31例；年龄60～85岁；美国麻醉医师协会（ASA）分级Ⅰ～Ⅱ级；体重指数（BMI）18.2～25.1 kg/m²。采用随机数字表法，将患者分为A组（25例）、B组（25例）、C组（25例）。3组均行静脉全身麻醉，A组采用丙泊酚麻醉（静脉注射），B组采用瑞马唑仑麻醉（静脉注射），C组采用瑞马唑仑复合丙泊酚麻醉（静脉注射）。比较3组麻醉效果（麻醉诱导时间、麻醉苏醒时间、麻醉恢复时间、复位时间）、血流动力学指标［平均动脉压（MAP）、心率（HR）］、应激指标［皮质醇（Cor）、肾上腺素、神经肽Y（NPY）］及不良反应（低血压、心动过缓、呼吸抑制、恶心呕吐、注射痛）。采用方差分析、LSD-t检验、χ²检验和Fisher确切概率法。结果　3组复位时间比较，差异无统计学意义（P>0.05）；C组麻醉诱导时间［（62.31±4.15）s］、苏醒时间［（17.26±3.45）min］、恢复时间［（6.25±1.56）min］均短于A组［（68.47±4.56）s、（21.47±4.29）min、（9.48±1.89）min］、B组［（69.85±4.66）s、（22.36±4.47）min、（9.24±1.85）min］（均P<0.05）；A组与B组麻醉诱导时间、苏醒时间、恢复时间比较，差异均无统计学意义（均P>0.05）。复位中、复位后，C组MAP［（85.77±4.29）mmHg（1 mmHg=0.133 kPa）、（85.36±4.27）mmHg］、HR［（75.21±3.76）次/min、（75.68±3.78）次/min］水平均低于A组［（89.29±4.46）mmHg、（88.73±4.44）mmHg、（79.24±3.96）次/min、（80.15±4.02）次/min］、B组［（90.21±4.51）mmHg、（89.56±4.47）mmHg、（78.33±3.93）次/min、（79.66±3.98）次/min］（均P<0.05）；A组与B组MAP、HR水平比较，差异均无统计学意义（均P>0.05）。复位后，C组Cor［（291.42±32.38）nmol/L］、肾上腺素［（211.47±14.11）μg/L］、NPY［（118.41±14.81）μg/L］水平均低于A组［（326.85±36.32）nmol/L、（231.46±15.43）μg/L、（137.65±17.21）μg/L］、B组［（321.54±34.73）nmol/L、（228.75±15.25）μg/L、（135.24±16.91）μg/L］（均P<0.05）；A组与B组Cor、肾上腺素、NPY水平比较，差异均无统计学意义（均P>0.05）。A组不良反应总发生率［56.00%（14/25）］高于B组［16.00%（4/25）］、C组［12.00%（3/25）］（均P<0.05）；B组与C组不良反应总发生率比较，差异无统计学意义（P>0.05）。结论　在BIS监测下瑞马唑仑复合丙泊酚用于老年髋关节脱位患者手法复位麻醉，不仅可减少用药剂量，还可增强麻醉效果，促进镇痛，且安全性良好。

关键词:

髋关节脱位, 老年, 手法复位, 脑电双频指数, 瑞马唑仑, 丙泊酚, 血流动力学, 应激反应

Abstract:

Objective　To explore the application effect of remimazolam combined with propofol in manual reduction of hip dislocation in elderly patients under bispectral index (BIS) monitoring. Methods　A total of 75 elderly patients with hip dislocation who underwent manual reduction in Shangluo Traditional Chinese Medicine Hospital from January 2021 to December 2022 were prospectively selected as the study objects. There were 44 males and 31 females, aged 60-85 years, the American Society of Anesthesiologists (ASA) grade was grade I to II, and the body mass index (BMI) was 18.2-25.1 kg/m². The patients were divided into group A (25 cases), group B (25 cases), and group C (25 cases) by the random number table method. All the three groups were given intravenous general anesthesia. Group A was given propofol (intravenous injection), group B was given remimazolam (intravenous injection), and group C was given remimazolam combined with propofol during manual reduction anesthesia (intravenous injection). The anesthetic effect (anesthetic induction time, anesthetic awakening time, anesthetic recovery time, and reduction time), hemodynamic indexes [mean arterial pressure (MAP) and heart rate (HR)], stress indexes [cortisol (Cor), adrenaline, and neuropeptide Y (NPY)], and adverse reactions (hypotension, bradycardia, respiratory depression, nausea and vomiting, and injection pain) were compared among the 3 groups. Analysis of variance, LSD-t test, χ² test, and Fisher exact probability method were used. Results　There was no statistically significant difference in the reduction time among the three groups (P>0.05). The anesthetic induction time [(62.31±4.15) s], awakening time [(17.26±3.45) min], and recovery time [(6.25±1.56) min] in group C were shorter than those in group A [(68.47±4.56) s, (21.47±4.29) min, and (9.48±1.89) min] and group B [(69.85±4.66) s, (22.36±4.47) min, and (9.24±1.85) min] (all P<0.05); there was no statistically significant difference in the anesthetic induction time, awakening time, or recovery time between group A and group B (all P>0.05). During and after reduction, the levels of MAP [(85.77±4.29) mmHg (1 mmHg=0.133 kPa) and (85.36±4.27) mmHg] and HR [(75.21±3.76) beats/min and (75.68±3.78) beats/min] in group C were lower than those in group A [(89.29±4.46) mmHg, (88.73±4.44) mmHg, (79.24±3.96) beats/min, and (80.15±4.02) beats/min] and group B [(90.21±4.51) mmHg, (89.56±4.47) mmHg, (78.33±3.93) beats/min, and (79.66±3.98) beats/min] (all P<0.05); there was no statistically significant difference in the level of MAP or HR between group A and group B (both P>0.05). After reduction, the levels of Cor [(291.42±32.38) nmol/L], epinephrine [(211.47±14.11) μg/L], and NPY [(118.41±14.81) μg/L] in group C were lower than those in group A [(326.85±36.32) nmol/L, (231.46±15.43) μg/L, and (137.65±17.21) μg/L] and group B [(321.54±34.73) nmol/L, (228.75±15.25) μg/L, and (135.24±16.91) μg/L] (all P<0.05); there was no statistically significant difference in the level of Cor, epinephrine, or NPY between group A and group B (all P>0.05). The total incidence of adverse reactions in group A [56.00% (14/25)] was higher than that in group B [16.00% (4/25)] and group C [12.00% (3/25)] (both P<0.05); there was no statistically significant difference in the total incidence of adverse reactions between group B and group C (P>0.05). Conclusion　Remimazolam combined with propofol for manual reduction anesthesia in elderly patients with hip dislocation under BIS monitoring can effectively improve the anesthetic effect, reduce the respective dosage, promote the analgesia, and is safe.

Key words:

Hip dislocation, Elderly, Manual reduction, Bispectral index, Remimazolam, Propofol, Hemodynamics, Stress response

吴磊孙彦妮牛青.

BIS监测下瑞马唑仑复合丙泊酚在老年髋关节脱位手法复位中的应用效果 [J]. 国际医药卫生导报, 2024, 30(20): 3442-3447.

Wu Lei, Sun Yanni, Niu Qing.

BIS monitoring the effect of remimazolam combined with propofol on manual reduction of hip dislocation in elderly patients [J]. International Medicine and Health Guidance News, 2024, 30(20): 3442-3447.

参考文献

[1] Page BJ, Parsons MS, Lee JH, et al. Surgical approach and dislocation risk after hemiarthroplasty in geriatric patients with femoral neck fracture with and without cognitive impairments-does cognitive impairment influence dislocation risk?[J]. J Orthop Trauma, 2023, 37(9):450-455. DOI: 10.1097/BOT.0000000000002614.
[2] Zanna L, Innocenti M, Secci G, et al. Acetabular morphology predicts the risk of dislocation following hemiarthroplasty for femoral neck fractures in the elderly[J]. J Arthroplasty, 2023, 38(9):1773-1778. DOI: 10.1016/j.arth.2023.02.042.
[3] Wakai A, Del Mar P. The evidence base for intra-articular lidocaine for closed manual reduction of acute anterior shoulder dislocation continues to grow[J]. CJEM, 2022, 24(8):797-798. DOI: 10.1007/s43678-022-00425-7.
[4] Song Y, Zou XJ. Remimazolam dosing for intraoperative sedation in elderly patients undergoing hip replacement with combined spinal-epidural anesthesia[J]. Eur Rev Med Pharmacol Sci, 2023, 27(16):7485-7491. DOI: 10.26355/eurrev_202308_33399.
[5] Gao J, Yang C, Ji Q, et al. Effect of remimazolam versus propofol for the induction of general anesthesia on cerebral blood flow and oxygen saturation in elderly patients undergoing carotid endarterectomy[J]. BMC Anesthesiol, 2023, 23(1):153. DOI: 10.1186/s12871-023- 02095-z.
[6] 王倩,王茂华,杨天爽,等.不同剂量瑞马唑仑复合丙泊酚应用于无痛胃镜检查的效果[J].临床麻醉学杂志,2022,38(2):163-166.DOI:10.12089/jca.2022.02.011.
[7] Chew WZ, Teoh WY, Sivanesan N, et al. Bispectral index (BIS) monitoring and postoperative delirium in elderly patients undergoing surgery: a systematic review and meta-analysis with trial sequential analysis[J]. J Cardiothorac Vasc Anesth, 2022, 36(12):4449-4459. DOI: 10.1053/j.jvca.2022.07.004.
[8] Friedberg BL. BIS monitoring transformed opioid-free propofol ketamine anesthesia from art to science for ambulatory cosmetic surgery[J]. Aesthetic Plast Surg, 2020, 44(6):2308-2311. DOI: 10.1007/s00266-020- 01987-6.
[9] Gervais HW. The ASA classification - solid like a rock in anesthesiology[J]. Anaesthesist, 2017, 66(1):3-4. DOI: 10.1007/s00101-016-0252-6.
[10] Rowan FE, Benjamin B, Pietrak JR, et al. Prevention of dislocation after total hip arthroplasty[J]. J Arthroplasty, 2018, 33(5):1316-1324. DOI: 10.1016/j.arth.2018.01.047.
[11] 张立秀,刘雪琴.蒙特利尔认知评估量表中文版的信效度研究[J].护理研究,2007,21(31):2906-2907.DOI:10.3969/j.issn.1009-6493.2007.31.044.
[12] 孙志红.氟比洛芬酯联合低分子肝素钠治疗对老年髋关节置换患者VAS评分及氧化应激反应的影响[J].实用医学杂志,2023,39(13):1693-1697.DOI:10.3969/j.issn.1006- 5725.2023.13.017.
[13] 武文亚,高钰琳,刘钕镝.基于知信行理论的干预模式在预防髋关节置换术后假体脱位中的应用效果[J].中国实用护理杂志,2022,38(8):580-587.DOI:10.3760/cma.j.cn211501-20210317-00800.
[14] Shin HJ, Woo Nam S, Kim H, et al. Postoperative delirium after dexmedetomidine versus propofol sedation in healthy older adults undergoing orthopedic lower limb surgery with spinal anesthesia: a randomized controlled trial[J]. Anesthesiology, 2023, 138(2):164-171. DOI: 10.1097/ALN.0000000000004438.
[15] Wang JH, Lv M, Zhang HX, et al. Impact of propofol versus sevoflurane on the incidence of postoperative delirium in elderly patients after spine surgery: study protocol of a randomized controlled trial[J]. Trials, 2022, 23(1):720. DOI: 10.1186/s13063-022-06687-x.
[16] Yu JJ, Pei HS, Meng Y. Successful remimazolam sedation-epidural block in an older patient with severe chronic obstructive pulmonary disease: a case report[J]. World J Clin Cases, 2023, 11(14):3330-3339. DOI: 10.12998/wjcc.v11.i14.3330.
[17] Aoki Y, Kurita T, Nakajima M, et al. Association between remimazolam and postoperative delirium in older adults undergoing elective cardiovascular surgery: a prospective cohort study[J]. J Anesth, 2023, 37(1):13-22. DOI: 10.1007/s00540-022-03119-7.
[18] 张彤彤,邢飞,李岩,等.瑞马唑仑复合丙泊酚用于患儿门诊根管治疗术镇静的效果[J].中华麻醉学杂志,2022,42(2):213-216.DOI:10.3760/cma.j.cn131073.20211018.00219.
[19] 张蓉,赵泽宇,王馨雪,等.瑞马唑仑复合小剂量丙泊酚用于麻醉诱导时镇静的效果[J].中华麻醉学杂志,2021,41(7):820-822.DOI:10.3760/cma.j.cn131073.20210518.00712.
[20] Sekiguchi R, Kinoshita M, Kawanishi R, et al. Comparison of hemodynamics during induction of general anesthesia with remimazolam and target-controlled propofol in middle-aged and elderly patients: a single-center, randomized, controlled trial[J]. BMC Anesthesiol, 2023, 23(1):14. DOI: 10.1186/s12871-023-01974-9.
[21] Tang F, Yi JM, Gong HY, et al. Remimazolam benzenesulfonate anesthesia effectiveness in cardiac surgery patients under general anesthesia[J]. World J Clin Cases, 2021, 9(34):10595-10603. DOI: 10.12998/wjcc.v9.i34.10595.
[22] Zhang J, Tu Q, Gan J, et al. Preemptive anti-stress response effects of oxycodone versus sufentanil for patients undergoing cardiac valve replacement-a randomized controlled trial[J]. Clin Pharmacol Drug Dev, 2020, 9(3):321-329. DOI: 10.1002/cpdd.764.
[23] Shan L, Si Q, Yao P. Effects of sodium hyaluronate administration on levels of antioxidant enzymes, serum substance P and neuropeptide Y in patients undergoing locking plate fixation for tibial plateau fractures[J]. Pak J Med Sci, 2023, 39(4):1040-1044. DOI: 10.12669/pjms.39.4.7460.
[24] Kuang Q, Zhong N, Ye C, et al. Propofol versus remimazolam on cognitive function, hemodynamics, and oxygenation during one-lung ventilation in older patients undergoing pulmonary lobectomy: a randomized controlled trial[J]. J Cardiothorac Vasc Anesth, 2023, 37(10):1996-2005. DOI: 10.1053/j.jvca.2023.06.027.
[25] 赵松雅,卢锡华,吕帅国,等.瑞马唑仑和丙泊酚对胸腹腔镜食管癌根治术老年患者术后恢复质量的影响[J].中华医学杂志,2023,103(17):1303-1309.DOI:10.3760/cma.j.cn112137-20221121-02449.
[26] 王建中,李婷婷,舒爱华,等.瑞马唑仑复合丙泊酚对无痛胃镜检查患者膈肌运动的影响[J].临床麻醉学杂志,2023,39(4):384-388.DOI:10.12089/jca.2023.04.009.
[27] Doi M, Morita K, Takeda J, et al. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase Ⅱb/Ⅲ trial[J]. J Anesth, 2020, 34(4):543-553. DOI: 10.1007/s00540-020-02788-6.